Standigm Companies
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.
Investors
Investors Number:
15.0
Total Funding:
71240000.0
Technology:
Artificial Intelligence, Biotechnology, Health Care, Machine Learning, Pharmaceutical
Estimated Revenue:
$1M to $10M
Employee Number:
101-250
Industry:
BioTech & Health Care
Founded Date:
2015-05-04
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Last Funding Date:
2021-06-30
Last Funding Type:
Series D
Investor Type:
For Profit
Funding Status:
Late Stage Venture